416 related articles for article (PubMed ID: 9126984)
21. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
23. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.
Pfeifer JD; Wick MJ; Roberts RL; Findlay K; Normark SJ; Harding CV
Nature; 1993 Jan; 361(6410):359-62. PubMed ID: 7678924
[TBL] [Abstract][Full Text] [Related]
24. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.
Serre K; Machy P; Grivel JC; Jolly G; Brun N; Barbet J; Leserman L
J Immunol; 1998 Dec; 161(11):6059-67. PubMed ID: 9834089
[TBL] [Abstract][Full Text] [Related]
25. Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response.
Yrlid U; Svensson M; Johansson C; Wick MJ
FEMS Immunol Med Microbiol; 2000 Apr; 27(4):313-20. PubMed ID: 10727887
[TBL] [Abstract][Full Text] [Related]
26. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.
Svensson M; Wick MJ
Eur J Immunol; 1999 Jan; 29(1):180-8. PubMed ID: 9933099
[TBL] [Abstract][Full Text] [Related]
27. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
Brooks AG; McCluskey J
J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726
[TBL] [Abstract][Full Text] [Related]
28. Processing of viable Salmonella typhimurium for presentation of a CD4 T cell epitope from the Salmonella invasion protein C (SipC).
Musson JA; Hayward RD; Delvig AA; Hormaeche CE; Koronakis V; Robinson JH
Eur J Immunol; 2002 Sep; 32(9):2664-71. PubMed ID: 12207351
[TBL] [Abstract][Full Text] [Related]
29. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
30. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
31. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
[TBL] [Abstract][Full Text] [Related]
32. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
Maecker HT; Umetsu DT; DeKruyff RH; Levy S
J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
[TBL] [Abstract][Full Text] [Related]
34. Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.
Rodríguez T; Pérez O; Ménager N; Ugrinovic S; Bracho G; Mastroeni P
Vaccine; 2005 Jan; 23(10):1312-21. PubMed ID: 15652674
[TBL] [Abstract][Full Text] [Related]
35. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
[TBL] [Abstract][Full Text] [Related]
36. Processing and presentation of intact hen egg-white lysozyme by dendritic cells.
De Bruijn ML; Nieland JD; Harding CV; Melief CJ
Eur J Immunol; 1992 Sep; 22(9):2347-52. PubMed ID: 1516625
[TBL] [Abstract][Full Text] [Related]
37. Activation of murine dendritic cells and macrophages induced by Salmonella enterica serovar Typhimurium.
Kalupahana RS; Mastroeni P; Maskell D; Blacklaws BA
Immunology; 2005 Aug; 115(4):462-72. PubMed ID: 16011515
[TBL] [Abstract][Full Text] [Related]
38. Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.
Keller SA; Bauer M; Manolova V; Muntwiler S; Saudan P; Bachmann MF
J Immunol; 2010 Jan; 184(1):26-9. PubMed ID: 19949081
[TBL] [Abstract][Full Text] [Related]
39. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
St-Pierre Y; Watts TH
J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
[TBL] [Abstract][Full Text] [Related]
40. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
